| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/29/2002 | WO2002066647A2 Type 2 ctokine receptor and nucleic acids encoding same |
| 08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
| 08/29/2002 | WO2002066636A2 T cell receptor variants expressed in mesenchymal cells and uses thereof |
| 08/29/2002 | WO2002066620A2 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system |
| 08/29/2002 | WO2002066619A1 Methods of treating inflammation, particularly diabetes |
| 08/29/2002 | WO2002066512A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | WO2002066511A2 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
| 08/29/2002 | WO2002066069A1 Remedies for inflammatory/tumor diseases |
| 08/29/2002 | WO2002066068A2 Method of treating neurological diseases |
| 08/29/2002 | WO2002066044A2 Method for dendritic cells based immunotherapy of tumors using combination therapy |
| 08/29/2002 | WO2002066040A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 08/29/2002 | WO2002065992A2 A cell therapy method for the treatment of tumors |
| 08/29/2002 | WO2002065989A2 Aminoglycoside treatment for lysosomal storage diseases |
| 08/29/2002 | WO2002065987A2 Production of platelet rich plasma and autologous procoagulant |
| 08/29/2002 | WO2002043649A3 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
| 08/29/2002 | WO2002022795A3 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2002016426A3 Coaster, a human coactivator of steroid receptors |
| 08/29/2002 | WO2002004001A3 A composition for the delivery of live cells and methods of use |
| 08/29/2002 | WO2001003515A9 Method of obtaining protein isolates and concentrates from colostrum |
| 08/29/2002 | WO2000059515A9 Immunomodulating polymers |
| 08/29/2002 | WO2000056866A9 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 08/29/2002 | WO2000023569A9 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/29/2002 | US20020120950 A homogenous cell mixture spontaneously sorting to form discrete first and second layers, e.g. keratinocytes and fibroblasts, and having a connective tissue component; skin grafts: testing a response to a chemical or a drug |
| 08/29/2002 | US20020120948 Modulating gene expression by regulation of cell proliferation; regulated transgene expression in lymphocytes by selective increase in the number of lymphocytes upon exposure to an antigen |
| 08/29/2002 | US20020120117 Polynucleotide that exhibits urothelial cell-specific transcriptional response element (TRE) activity; adenoviral vectors which replicate preferentially in urothelial cells; treating bladder cancer for example |
| 08/29/2002 | US20020119928 Mixture of colostrum, lactoferrin, pectin and glucan |
| 08/29/2002 | US20020119923 Administering macrophage derived compound |
| 08/29/2002 | US20020119880 Method and apparatus for processing blood and blood components |
| 08/29/2002 | US20020119571 Stimulating lymphocytes of graft recipient by cells of graft donor or by cells expressing dominant Major Histocompatability Complex-molecules while transduced with immunmodulatory genes using gene transfer; prevents rejection of allogeneic grafts |
| 08/29/2002 | US20020119568 Providing a population of cells having a target cell surface molecule, a culture vessel and magnets, vessel contains a solid surface having attached thereto a ligand for a target cell surface molecule, applying magnetic field |
| 08/29/2002 | US20020119566 Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
| 08/29/2002 | US20020119565 Isolation and use of solid tumor stem cells |
| 08/29/2002 | US20020119562 Method for selecting improved vectors |
| 08/29/2002 | US20020119204 Composition and method for growing hair |
| 08/29/2002 | US20020119147 Apparatus for enhancing immune responses in mammals |
| 08/29/2002 | US20020119145 Tyrissamycin antibiotic |
| 08/29/2002 | US20020119143 Antithrombin III for disorders caused by angiogenesis |
| 08/29/2002 | US20020119128 Graft acceptance through manipulation of thymic regeneration |
| 08/29/2002 | US20020119126 Culturing adipose stromal cells in a medium capable of supporting the growth of fibroblasts and differentiation inducing amounts of beta - glycerophosphate and ascorbic acid and/or ascorbic-2 phosphate |
| 08/29/2002 | US20020119125 Microencapsulated pheochromocyte of ox adrenal medulla as medicine for curing pain |
| 08/29/2002 | US20020119121 Compositions and methods for inducing specific cytolytic T cell responses |
| 08/29/2002 | US20020119119 Administering natural killer cell activating cytokine or flavonoid, wherein cytokine is not IL-2 or IFN-alpha; administering histamine or serotonin or H2 receptor agonists to inhibit production or release of hydrogen peroxide |
| 08/29/2002 | CA2698079A1 A cell therapy method for the treatment of tumors |
| 08/29/2002 | CA2438775A1 T cell receptor variants expressed in mesenchymal cells and uses thereof |
| 08/29/2002 | CA2438754A1 A cell therapy method for the treatment of tumors |
| 08/29/2002 | CA2438750A1 Aminoglycoside treatment for lysosomal storage diseases |
| 08/29/2002 | CA2438518A1 Method of treating neurological diseases |
| 08/29/2002 | CA2438235A1 Neurotransmission-associated proteins |
| 08/29/2002 | CA2437980A1 Methods of treating inflammation, particularly diabetes |
| 08/29/2002 | CA2436399A1 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
| 08/29/2002 | CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/29/2002 | CA2432932A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | CA2426659A1 Method for treatment of tumors using combination therapy |
| 08/28/2002 | EP1234553A1 Bioartificial device |
| 08/28/2002 | EP1234048A2 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 08/28/2002 | EP1234044A2 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 08/28/2002 | EP1234043A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/28/2002 | EP1234034A1 Transfer compounds, the production and the use thereof |
| 08/28/2002 | EP1234031A2 B7-h1, a novel immunoregulatory molecule |
| 08/28/2002 | EP1234024A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 08/28/2002 | EP1234021A2 Methods and compositions for enhancing developmental potential of oocytes and zygotes |
| 08/28/2002 | EP1233975A1 29 human secreted proteins |
| 08/28/2002 | EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP0988063B1 Process for reducing the concentration of viral and molecular pathogens in a biological material |
| 08/28/2002 | EP0808173B1 Product and method for preventing respiratory virus infection |
| 08/28/2002 | CN1366062A Recombination carrier and treating composition used in insulin dependent diabetes gene curing |
| 08/28/2002 | CN1365827A Exterior-applied medicine for treating osteopathy |
| 08/28/2002 | CN1365824A Medicine for treating hyperosteogeny and bone retromorphosis and its preparing process |
| 08/28/2002 | CN1365819A Medicine for treating apoplexy |
| 08/28/2002 | CN1365817A Chinese medicine (instant particles) for treating intractable tinea and its preparing process |
| 08/28/2002 | CN1365669A Bone-building up powder |
| 08/28/2002 | CN1365668A Active centipede extract for suppressing cancer and its extracting process |
| 08/28/2002 | CN1089608C Process for producing transfer factors resisting virus of respiratory tract |
| 08/28/2002 | CN1089607C Immunomodulatory complex for helicobacter bacteria |
| 08/28/2002 | CN1089603C Liquid medicine for treating diseases of eye, ear, nose and throat |
| 08/28/2002 | CN1089600C Medicine for treating leukemia |
| 08/28/2002 | CN1089599C Traditional Chinese medicinal preparation for treating pulmonary tuberculosis |
| 08/28/2002 | CN1089598C Traditional Chinese medical preparation for fracture setting |
| 08/28/2002 | CN1089597C Psoriasis treating Chinese medicine preparation and its preparing process |
| 08/28/2002 | CN1089594C Traditional Chinese medicine for curing psoriasis |
| 08/28/2002 | CN1089593C Chinese medicinal preparation for treatment of toothache and method for preparation thereof |
| 08/28/2002 | CN1089592C Chinese medicine for treating acute and chronic nephritis |
| 08/28/2002 | CN1089591C Medical power or capsule for treating gastropathies |
| 08/28/2002 | CN1089546C Method for raising pigs and promoting them stronger |
| 08/27/2002 | US6441144 Method for repairing dual virally inactivated immune globulin for intravenous administration |
| 08/27/2002 | US6440944 Methods of administering adenoviral vectors |
| 08/27/2002 | US6440736 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 08/27/2002 | US6440735 Dendritic cell vaccine containing telomerase reverse transcriptase for the treament of cancer |
| 08/27/2002 | US6440734 Insertion into porous solid matrix |
| 08/27/2002 | US6440732 Checkpoint/repair genes involved with dna repair prior to replication; aging resistance; cancer therapy |
| 08/27/2002 | US6440663 Renal cancer associated antigens and uses therefor |
| 08/27/2002 | US6440464 Lozenges |
| 08/27/2002 | US6440452 Therapeutic enclosures |
| 08/27/2002 | US6440448 Plant and/or animal extract, antioxidant, orally ingestible carrier; antitumor and anticarcinogenic agents; aging resistance; storage stability |
| 08/27/2002 | US6440426 Antigen-containing formulation and methods of use thereof |
| 08/27/2002 | US6440422 Expressing foreign genes inserted at site of naturally occurring deletion in modified vaccinia virus ankara genome; polypeptides, e.g. antigens or therapeutic agents, or viral vectors for gene therapy; encoding antigens as vaccines |
| 08/27/2002 | US6440413 Selectively destroying subunit a without destroying subunit b of cholera toxin; enzyme with preponderance of exocellular proteinase produced by a culture of streptomyces fradiae; hyperviscosity of intestinal, bronchial and/or genital mucus |
| 08/27/2002 | US6440412 Purified forms of DNase |
| 08/27/2002 | US6440409 Method for efficient and highly selective control of microorganisms |